The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm
Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study was to to evaluate the effect of sarpogrelate, a selective serotonin
receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients
with variant angina.